von Haehling S - Search Results

1

Espindolol for the treatment and prevention of cachexia in patients with stage III/IV non-small cell lung cancer or colorectal cancer: a randomized, double-blind, placebo-controlled, international multicentre phase II study (the ACT-ONE trial).

Stewart Coats AJ, Ho GF, Prabhash K, von Haehling S, Tilson J, Brown R, Beadle J, Anker SD; for and on behalf of the ACT‐ONE study group. Stewart Coats AJ, et al. Among authors: von haehling s. J Cachexia Sarcopenia Muscle. 2016 Jun;7(3):355-65. doi: 10.1002/jcsm.12126. Epub 2016 Jul 1. J Cachexia Sarcopenia Muscle. 2016. PMID: 27386169 Free PMC article.

2

Effect of interleukin-10 on the production of tumor necrosis factor-alpha by peripheral blood mononuclear cells from patients with chronic heart failure.

Bolger AP, Sharma R, von Haehling S, Doehner W, Oliver B, Rauchhaus M, Coats AJ, Adcock IM, Anker SD. Bolger AP, et al. Among authors: von haehling s. Am J Cardiol. 2002 Aug 15;90(4):384-9. doi: 10.1016/s0002-9149(02)02494-3. Am J Cardiol. 2002. PMID: 12161227

3

Pathophysiologic quantities of endotoxin-induced tumor necrosis factor-alpha release in whole blood from patients with chronic heart failure.

Genth-Zotz S, von Haehling S, Bolger AP, Kalra PR, Wensel R, Coats AJ, Anker SD. Genth-Zotz S, et al. Among authors: von haehling s. Am J Cardiol. 2002 Dec 1;90(11):1226-30. doi: 10.1016/s0002-9149(02)02839-4. Am J Cardiol. 2002. PMID: 12450603

4

beta-blockers in heart failure--much more than heart rate reduction.

Von Haehling S, Anker SD. Von Haehling S, et al. J Card Fail. 2002 Dec;8(6):379-80. doi: 10.1054/jcaf.2002.130310. J Card Fail. 2002. PMID: 12528089 No abstract available.

5

Statins and the role of nitric oxide in chronic heart failure.

von Haehling S, Anker SD, Bassenge E. von Haehling S, et al. Heart Fail Rev. 2003 Jan;8(1):99-106. doi: 10.1023/a:1022103222857. Heart Fail Rev. 2003. PMID: 12652163 Review.

6

The relationship between age and production of tumour necrosis factor-alpha in healthy volunteers and patients with chronic heart failure.

von Haehling S, Genth-Zotz S, Sharma R, Bolger AP, Doehner W, Barnes PJ, Coats AJ, Anker SD. von Haehling S, et al. Int J Cardiol. 2003 Aug;90(2-3):197-204. doi: 10.1016/s0167-5273(02)00566-1. Int J Cardiol. 2003. PMID: 12957752

7

Tumour necrosis factor-alpha and the failing heart--pathophysiology and therapeutic implications.

von Haehling S, Jankowska EA, Anker SD. von Haehling S, et al. Basic Res Cardiol. 2004 Jan;99(1):18-28. doi: 10.1007/s00395-003-0433-8. Epub 2003 Aug 21. Basic Res Cardiol. 2004. PMID: 14685702 Review.

8

Inflammatory mediators in chronic heart failure: an overview.

Anker SD, von Haehling S. Anker SD, et al. Among authors: von haehling s. Heart. 2004 Apr;90(4):464-70. doi: 10.1136/hrt.2002.007005. Heart. 2004. PMID: 15020532 Free PMC article. No abstract available.

9

Heat shock protein 70 in patients with chronic heart failure: relation to disease severity and survival.

Genth-Zotz S, Bolger AP, Kalra PR, von Haehling S, Doehner W, Coats AJ, Volk HD, Anker SD. Genth-Zotz S, et al. Among authors: von haehling s. Int J Cardiol. 2004 Sep;96(3):397-401. doi: 10.1016/j.ijcard.2003.08.008. Int J Cardiol. 2004. PMID: 15301893

10

Impact of levosimendan treatment on chronic heart failure.

von Haehling S, Diller GP, Anker SD. von Haehling S, et al. Am J Cardiol. 2004 Oct 15;94(8):1105. doi: 10.1016/j.amjcard.2004.05.078. Am J Cardiol. 2004. PMID: 15476643 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

530 results

Search Page

Filters